Evidence map›Paper›PMID 40102910›Full record

ArticleAnnals of clinical microbiology and antimicrobials2025

Molecular and genetic features of a bla

Yuting Kang, Qiujie Li, Wanting Ma, Chao Xu, Zhuoran Qiu, Wei Jia, Pengtao Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuting Kang *Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, 750004, Ningxia, China.
Qiujie Li *First Clinical Medical College, Ningxia Medical University, Yinchuan, 750004, Ningxia, China.
Wanting MaFirst Clinical Medical College, Ningxia Medical University, Yinchuan, 750004, Ningxia, China.
Chao XuFirst Clinical Medical College, Ningxia Medical University, Yinchuan, 750004, Ningxia, China.
Zhuoran QiuFirst Clinical Medical College, Ningxia Medical University, Yinchuan, 750004, Ningxia, China.
Wei JiaNingxia Key Laboratory of Clinical and Pathogenic Microbiology, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, 750004, Ningxia, China. jiawei6365@126.com.
Pengtao WangNingxia Key Laboratory of Clinical and Pathogenic Microbiology, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, 750004, Ningxia, China. wangpengtao2021@163.com.

Funding

Open Project of Ningxia Key Laboratory of Clinical and Pathogenic Microbiology MKLG-2024-11
6 · The paper itself

Abstract

purposeThis study aimed to assess the resistance phenotype, virulence phenotype, and genetic characteristics of a bla

methodsAntibiotic susceptibility test was determined by Vitek 2 Compact system. Multilocus Sequence typing (MLST), antimicrobial resistance and virulence genes were examined by PCR and Sanger sequencing. The virulence of KP114 was evaluated through string test, macrophage phagocytosis assay, serum resistance assay, and mouse infection model. Whole-genome sequencing was performed for further analysis of genetic information.

resultsThe presence of the bla

conclusionsWe reported a Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) strain of ST65 K2 serotype carrying the bla

Indexed as

beta-LactamasesKlebsiella InfectionsKlebsiella pneumoniaeAnimalsAnti-Bacterial AgentsBacterial ProteinsDisease Models, AnimalDrug Resistance, Multiple, BacterialFemaleHumansMiceMicrobial Sensitivity TestsMultilocus Sequence TypingPlasmidsSerogroupVirulenceAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase NDM-1beta-LactamasesVirulence Factorsbla NDM−1Drug resistanceKlebsiella pneumoniaeSerotype K2ST65Virulence plasmid

Identifiers

PMID40102910
PMCPMC11921603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.